...
首页> 外文期刊>Science Advances >A new algorithm to convert a normal antibody into the corresponding catalytic antibody
【24h】

A new algorithm to convert a normal antibody into the corresponding catalytic antibody

机译:将正常抗体转化为相应催化抗体的新算法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Over thousands of monoclonal antibodies (mAbs) have been produced so far, and it would be valuable if these mAbs could be directly converted into catalytic antibodies. We have designed a system to realize the above concept by deleting Prosup95/sup, a highly conserved residue in CDR-3 of the antibody light chain. The deletion of Prosup95/sup is a key contributor to catalytic function of the light chain. The S35 and S38 light chains have identical amino acid sequences except for Prosup95/sup. The former, with Prosup95/sup did not show any catalytic activity, whereas the latter, without Prosup95/sup, exhibited peptidase activity. To verify the generality of this finding, we tested another light chain, T99wt, which had Prosup95/sup and showed little catalytic activity. In contrast, a Prosup95/sup-deleted mutant enzymatically degraded the peptide substrate and amyloid-beta molecule. These two cases demonstrate the potential for a new method of creating catalytic antibodies from the corresponding mAbs.
机译:到目前为止,已经产生了超过成千上万的单克隆抗体(MAB),如果这些mAb可以直接转化为催化抗体,则会有价值。我们设计了一种通过删除PRO 95 ,在抗体轻链的CDR-3中的高度保守的残留物中实现上述概念。 Pro 95 的删除是轻链催化功能的关键因素。除Pro 95 之外,S35和S38光链具有相同的氨基酸序列。前者,具有Pro 95 未显示任何催化活性,而后者没有Pro 95 ,表现出肽酶活性。为了验证该发现的一般性,我们测试了另一种轻链T99WT,其具有Pro 95 并显示出很少的催化活性。相反,酶促突变体酶促降解肽底物和淀粉样蛋白β分子的PRO 95。这两种病例证明了一种从相应的mAb产生催化抗体的新方法的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号